Title
Ban on Trovafloxacin due to liver risks
Law
Bfad Administrative Order No. 1, S. 2000
Decision Date
Jan 3, 2000
Trovafloxacin (Trovan) is banned and recalled from the market due to serious and unpredictable hepatic risks, including potential liver failure and death, following recommendations from the National Drug Committee and the World Health Organization.
A

Analyze Cases Smarter, Faster
Jur helps you analyze cases smarter to comprehend faster, building context before diving into full texts. AI-powered analysis, always verify critical details.